If you want to play the graying of America, Humana (NYSE: HUM )
is a name to consider. This managed care provider may be as close as
you can find to a pure play on Medicare Advantage, as this program is
more than two-thirds of the company's earnings base. At the same time,
Humana has joined Aetna (NYSE: AET ) and WellPoint (NYSE: WLP ) as the most aggressive participants in the new public exchanges.
Humana apparently isn't afraid to take on risk, as Medicare Advantage
rates have become a great deal more uncertain and nobody really knows
how the new Obamacare-mandated exchanges are going to work out. Humana
looks about as undervalued as Aetna or Cigna (NYSE: CI )
and could be priced to generate some solid long-term returns, but
investors have to be comfortable with the risks and uncertainties that
go with such a large commitment to the Medicare Advantage program.
Read more here:
Humana Inc.: The Way To Play Medicare Advantage
No comments:
Post a Comment